AFLIDE-200
February 20, 2026
AFLIDE-CV
February 20, 2026
AFLIDE-CV
₹130.00
Composition:
Cefpodoxime Proxetil: 50 mg, Potassium Clavulanate: 125 mg
Packaging Detail:
5gm/30ml
Description
AFLIDE-CV oral suspension combines the antibiotic Cefpodoxime with Potassium Clavulanate, a beta-lactamase inhibitor. Clavulanate protects Cefpodoxime from being destroyed by certain enzymes produced by bacteria, extending its spectrum of activity.
Indications
Indications
-
Pediatric infections caused by beta-lactamase producing strains.
-
Acute otitis media.
-
Sinusitis and tonsillitis.
-
Lower respiratory tract infections.
Side Effects
Side Effects
-
Diarrhea is more common than with Cefpodoxime alone.
-
Nausea, vomiting, and abdominal pain.
-
Skin rash and urticaria.
-
Vaginal candidiasis (yeast infection).
-
Rare cases of liver dysfunction.
Reviews 0
Related products
-
ZYME-MEL KID
₹205.00 -
RETAMEL
₹135.00 -
ACPANAC-P
₹56.00
Reviews
There are no reviews yet.